Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Circ Cardiovasc Genet. 2009 Jun 3;2(5):428–435. doi: 10.1161/CIRCGENETICS.109.858217

Table 4.

Gender differences

Male (n=48) Female (n=34) P-value
Mutation 30 (63%) 13 (38%) 0.03
Age diagnosis, yrs 38±16 35±10 0.35
Age first ARVD related symptoms, yrs 34±15 32±12 0.55
Family history, n (%) 15 (31%) 16 (47%) 0.15
 Family history proven on autopsy 9 (19%) 9 (27%) 0.40
Repolarization abnormalities, n (%) 41 (87%) 32 (94%) 0.21
Depolarization abnormalities, n (%) 41 (89%) 23 (70%) 0.03
 Major depolarization abnormalities 28 (61%) 9 (28%) 0.004
LBBB-VT on ECG, Holter or stress-ECG 31 (67%) 16 (47%) 0.07
Age of first recorded VT 37±15 37±11 0.93
Structural alterations, n (%) 46 (96%) 32 (94%) 1.00
Minor dysfunction and structural alterations, n (%) 20 (42%) 22 (65%) 0.04
Major dysfunction and structural alterations, n (%) 26 (54%) 10 (29%) 0.026
Fibrofatty replacement on endomyocardial biopsy, n (%) 9 (53%) 4 (25%) 0.10

Repolarization abnormalities are considered present if there is T-wave inversion in ECG leads V1, V2, and V3 for those aged > 14 years in the absence of right bundle branch block. Depolarization abnormalities are considered major if there are epsilon waves or localized prolongation (>110ms) of the QRS complex in right precordial leads (V1–V3), and minor if there are late potentials on signal-averaged ECG. P-values that are below 0.05 are indicated with bold-faced text.